143 related articles for article (PubMed ID: 720492)
1. Inhibition of Ehrlich ascites carcinoma (EAC) growth by carbonyl iron.
Pessina A; Brambilla P; Balzarin D
Experientia; 1978 Nov; 34(11):1518-9. PubMed ID: 720492
[TBL] [Abstract][Full Text] [Related]
2. C-glycosyl Flavone from Urginea indica Inhibits Growth and Dissemination of Ehrlich Ascites Carcinoma Cells in Mice.
Bevara GB; Kumar ADN; Koteswramma K L; Badana AK; Kumari S; Yarla NS; Malla RR
Anticancer Agents Med Chem; 2017; 17(9):1256-1266. PubMed ID: 28044935
[TBL] [Abstract][Full Text] [Related]
3. [The mitosis rate in Jensen sarcoma, in a DANA lung carcinoma and in Ehrlich ascites tumor in iron deficiency and iron overloading].
Kranz D; Schmidt UJ; Kalbe I; Brüschke G; Pasternak G
Acta Biol Med Ger; 1969; 22(3):653-6. PubMed ID: 4903492
[No Abstract] [Full Text] [Related]
4. Influence of melatonin on proliferation and antioxidant system in Ehrlich ascites carcinoma cells.
El-Missiry MA; Abd El-Aziz AF
Cancer Lett; 2000 Apr; 151(2):119-25. PubMed ID: 10738105
[TBL] [Abstract][Full Text] [Related]
5. Antineoplastic activity of N-(2-hydroxybenzylidene)2'-hydroxyphenylimine aqua nickel(II) complex [NI(H₂O)HHP] on ehrlich ascites carcinoma (EAC) in Swiss albino mice.
Hossain IA; Khanam JA; Jesmin M; Ali MM
Exp Toxicol Pathol; 2016 Jan; 68(1):15-25. PubMed ID: 26404919
[TBL] [Abstract][Full Text] [Related]
6. The triterpenoid fraction from Trichosanthes dioica root exhibits antiproliferative activity against Ehrlich ascites carcinoma in albino mice: involvement of possible antioxidant role.
Bhattacharya S; Haldar PK
J Exp Ther Oncol; 2012; 9(4):281-90. PubMed ID: 22545421
[TBL] [Abstract][Full Text] [Related]
7. Iron N-(2-hydroxy acetophenone) glycinate (FeNG), a non-toxic glutathione depletor circumvents doxorubicin resistance in Ehrlich ascites carcinoma cells in vivo.
Ganguly A; Chakraborty P; Banerjee K; Chatterjee S; Basu S; Sarkar A; Chatterjee M; Choudhuri SK
Biometals; 2012 Feb; 25(1):149-63. PubMed ID: 21915630
[TBL] [Abstract][Full Text] [Related]
8. In vitro and in vivo evaluation of anisomycin against Ehrlich ascites carcinoma.
You P; Xing F; Huo J; Wang B; Di J; Zeng S; Liu J
Oncol Rep; 2013 Jun; 29(6):2227-36. PubMed ID: 23525555
[TBL] [Abstract][Full Text] [Related]
9. The antitumor effects of tetrodotoxin and/or doxorubicin on Ehrlich ascites carcinoma-bearing female mice.
El-Dayem SM; Fouda FM; Ali EH; Motelp BA
Toxicol Ind Health; 2013 Jun; 29(5):404-17. PubMed ID: 22317827
[TBL] [Abstract][Full Text] [Related]
10. Antitumor activity and antioxidant role of Bauhinia racemosa against Ehrlich ascites carcinoma in Swiss albino mice [corrected].
Gupta M; Mazumder UK; Kumar RS; Kumar TS
Acta Pharmacol Sin; 2004 Aug; 25(8):1070-6. PubMed ID: 15301742
[TBL] [Abstract][Full Text] [Related]
11. Antitumor activity of picolinic acid in CBA/J mice.
Leuthauser SW; Oberley LW; Oberley TD
J Natl Cancer Inst; 1982 Jan; 68(1):123-6. PubMed ID: 6948122
[TBL] [Abstract][Full Text] [Related]
12. Ameliorative effects of vitamin B17 on the kidney against Ehrlich ascites carcinoma induced renal toxicity in mice.
Mutar TF; Tousson E; Hafez E; Abo Gazia M; Salem SB
Environ Toxicol; 2020 Apr; 35(4):528-537. PubMed ID: 31821727
[TBL] [Abstract][Full Text] [Related]
13. Effects of bleomycin on the cell cycle of Ehrlich ascites carcinoma.
Nagatsu M; Richart RM; Lambert A
Cancer Res; 1972 Sep; 32(9):1966-70. PubMed ID: 4118376
[No Abstract] [Full Text] [Related]
14. Trehalose enhances the antitumor potential of methotrexate against mice bearing Ehrlich ascites carcinoma.
El-Magd MA; Khamis A; Nasr Eldeen SK; Ibrahim WM; Salama AF
Biomed Pharmacother; 2017 Aug; 92():870-878. PubMed ID: 28599251
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of Hep2 and HeLa cell proliferation in vitro and EAC tumor growth in vivo by Lapemis curtus (Shaw 1802) venom.
Karthikeyan R; Karthigayan S; Sri Balasubashini M; Somasundaram ST; Balasubramanian T
Toxicon; 2008 Jan; 51(1):157-61. PubMed ID: 17936322
[TBL] [Abstract][Full Text] [Related]
16. In vivo suppression of Ehrlich ascites carcinoma by human antibody-dependent splenocytes.
Dobaczewska H
Neoplasma; 1984; 31(2):165-8. PubMed ID: 6717686
[TBL] [Abstract][Full Text] [Related]
17. Chloroaceto hydroxamic acid as antitumor agent against Ehrlich ascites carcinoma in mice.
Sur P; Bag SP; Sur B; Khanam JA
Neoplasma; 1997; 44(3):197-201. PubMed ID: 9372863
[TBL] [Abstract][Full Text] [Related]
18. Resistance to Ehrlich ascites tumor in a strain of dystrophic mice.
Carry PJ; Prescott DM; Ogilvie GK
Cancer Res; 1979 Jun; 39(6 Pt 1):2139-40. PubMed ID: 445411
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of growth of Ehrlich ascites tumors in ICR-Ha Swiss mice by isocyanates.
Moos GE; Maguire JA; Kitchlew TZ; Swyers WA; Volk PZ; Croft JR; Quigley MJ; Fries JR; Oser NA; Anderson LJ
Cancer Res; 1971 Jul; 31(7):937-41. PubMed ID: 5560387
[No Abstract] [Full Text] [Related]
20. Cytotoxic and antitumor effects of brucine on Ehrlich ascites tumor and human cancer cell line.
Agrawal SS; Saraswati S; Mathur R; Pandey M
Life Sci; 2011 Aug; 89(5-6):147-58. PubMed ID: 21684292
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
